• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Wiki Aapc study guide chapter 3

Create Wiki
K

Kieferz

Guest
Messages
12
Best answers
0
On question 8 of the study guide on chapter 3 it states: four years post hepatic transplant, the patient is diagnosed with combined hepatocellular carcinoma and cholangiocarcinoma of the liver. Code the patients condition. It says to use 155.0 to correctly code the neoplasm. But why wouldn't it be 155.2 because it is not specified as primary or secondary.
 
Kieferz said:
On question 8 of the study guide on chapter 3 it states: four years post hepatic transplant, the patient is diagnosed with combined hepatocellular carcinoma and cholangiocarcinoma of the liver. Code the patients condition. It says to use 155.0 to correctly code the neoplasm. But why wouldn't it be 155.2 because it is not specified as primary or secondary.
Click to expand...

If you look under the 155 ICD-9 section and refer to 155.0, Liver,primary, it says Carcinoma and indented under Carcinoma it says Hepatocellular. That is why you use 155.0. Hepatocellular is mentioned under primary and is specific. Always code to the highest specificity. 155.2 is not specific.
Hope this makes sense
 
You must log in or register to reply here.
Top